NIH: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional)

Sponsor Deadline: 

Mar 20, 2018

Internal Deadline: 

Feb 6, 2018

Sponsor: 

NIH National Institute of Diabetes, Digestive and Kidney Diseases

Updated Date: 

Jan 8, 2018

NIH: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Optional)

Limited to one per organization

Internal Deadline: 2/6/2018

NIH Deadline: 3/20/2018

 

NIH: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 - Clinical Trial Optional)

Limited to one per organization

Internal Deadline: 2/6/2018

NIH Deadline: 3/20/2018

Categories: 

Keywords: